Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

Anecdotal evidence does point to efficacy against at least one type ovarian cancer. There is the woman who reportedly had 7 cycles of Kevetrin, all below 50 mg/m^2. Before a patient can receive an additional cycle there must be a perceived benefit, whatever "perceived benefit" might mean. I'm also thinking a possible trial against pancreatic cancer, though Ovarian was the only example given.